The aim of this study is to establish the optimal screening method and cut-off value (COV) for GALK deficiency screening by performing a systematic review of screening strategies and total galactose (TGAL) values and by evaluating TGAL values of screened newborns in the Netherlands. The gene discussed is GALK1; the disease is hyperinsulinemic hypoglycemia, familial, 4.